Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
oleh: Christopher J. Fay, BA, Dorsa Moslehi, BA, Christopher Iriarte, MD, Timothy M. Dang, MD, Cesar A. Virgen, MD, PhD, Eleanor Russell-Goldman, MD, PhD, Nicole R. LeBoeuf, MD, MPH
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-09-01 |
Deskripsi
Subjek
cutaneous Rosai-Dorfman disease; histiocytic disorders; MEK inhibitor; methotrexate; non-Langerhans cell histiocytosis; Rosai–Dorfman disease